8-KEarnings & ResultsExhibits & Filings

GE HealthCare Technologies Inc. 8-K Report, Financial Results (Oct 31, 2023)

Filed October 31, 2023For Securities:GEHC

Summary

GE HealthCare Technologies Inc. (GEHC) filed an 8-K on October 31, 2023, to report its third quarter 2023 financial results. The primary purpose of this filing is to furnish a press release detailing these results, which serves as the key information source for investors regarding the company's recent performance. While the 8-K itself doesn't contain extensive operational details beyond referencing the press release, it signifies the official disclosure of the quarterly financial outcomes. Investors should refer to the furnished press release (Exhibit 99) for a comprehensive understanding of GE HealthCare's third quarter performance. This typically includes key financial metrics such as revenue, earnings per share (EPS), segment performance, and any forward-looking guidance provided by the company. The information within the press release is crucial for assessing the company's operational health, growth trajectory, and overall financial standing in the current market environment.

Key Highlights

  • 1GE HealthCare Technologies Inc. (GEHC) reported its third quarter 2023 financial results via an 8-K filing on October 31, 2023.
  • 2The 8-K filing primarily serves to furnish the company's earnings press release (Exhibit 99).
  • 3Investors must consult the press release for detailed financial performance data, including revenue and earnings.
  • 4The filing indicates that the information furnished is not deemed 'filed' for specific sections of securities law, but is critical for understanding quarterly performance.
  • 5This report provides the official channel for GEHC to communicate its Q3 2023 financial outcomes to the market.

Frequently Asked Questions

The detailed financial results for GE HealthCare's third quarter 2023 are available in the press release furnished as Exhibit 99 to the 8-K filing dated October 31, 2023.

This 8-K filing is significant because it officially announces and provides access to GE HealthCare's third quarter 2023 financial results through the attached press release. It is the primary source for investors to review the company's performance during the quarter.

The 8-K filing itself primarily directs investors to the press release for financial results. Any detailed operational or strategic commentary would typically be found within that press release (Exhibit 99), not extensively within the 8-K form itself.

According to the filing, the information furnished under Item 2.02 (including the press release) is not deemed 'filed' for purposes of Section 18 of the Exchange Act or subject to the liabilities under that section, unless expressly incorporated by reference into another filing.